Investor Relations

You are here:

Corporate Governance

ChemoTech is a Swedish public limited liability company. The Company was established in Sweden. The present Company’s date of registration with the Swedish Companies Registration Office is 25 February 2015, and the Company has been in operation since then. The Company complies with the regulations of the Swedish Companies Act (2005:551) and other applicable statutory regulations. The Company is domiciled in Lund, Sweden.

The basis for the Company’s activities is its Articles of Association. In accordance with Article 3 of the Articles of Association, the Company conducts development, production and marketing of medicotechnical equipment, and related activities. The Company’s Annual General Meeting adopts the Articles of Association and annually appoints the Board of Directors. The Board of Directors is responsible for the organisation and management of the Company, and the appointment or dismissal of the CEO. The Board of Directors annually lays down written procedures for its work, combined with CEO instructions for the division of work between the Board of Directors and the CEO. Matters concerning remuneration or auditing are decided directly by the Company’s Board of Directors. All members of the Board of Directors are elected for a term up to the next Annual General Meeting. Each member of the Board of Directors is entitled to resign at any time.

Investor Relations Contact

[email protected]

Scandinavian ChemoTech AB
Medicon Village Scheeletorget 1
SE-223 63 Lund, Sweden

Certified Advisor

The Company’s Certified Adviser is Redeye AB. The Certified Adviser continuously assists and reviews the Company to ensure that it complies with the Nasdaq First North rules and regulations.

Redeye AB
Mäster Samuelsgatan 42
111 57 Stockholm

Tel: ++46 (0)8 – 121 576 90

[email protected]


MAZARS SET Revisionsbyrå AB
Auditor responsible Karin Löwhagen
Deputy auditor Filip Åkesson